Eledon Pharmaceuticals, Inc. Operating Expenses
Eledon Pharmaceuticals, Inc. (ELDN) reported Operating Expenses of $22.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. operating expenses for the quarter ending 2026-06-30 was $22.87M, a 7.54% decline year-over-year.
- Eledon Pharmaceuticals, Inc. operating expenses for the quarter ending 2026-03-31 was $21.18M, a 17.91% increase year-over-year.
- Eledon Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-12-31 was $21.48M, a 13.01% decline year-over-year.
- Eledon Pharmaceuticals, Inc. operating expenses for the quarter ending 2025-09-30 was $19.07M, a 7.02% decline year-over-year.
- Eledon Pharmaceuticals, Inc. operating expenses for fiscal 2025 was $83.25M, a 17.96% increase from fiscal 2024.
- Eledon Pharmaceuticals, Inc. operating expenses for fiscal 2024 was $70.58M, a 64.13% increase from fiscal 2023.
- Eledon Pharmaceuticals, Inc. operating expenses for fiscal 2023 was $43.00M, a 51.37% decline from fiscal 2022.
- Eledon Pharmaceuticals, Inc. operating expenses for fiscal 2022 was $88.43M, a 139.86% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.87M 10-Q · filed 2026-08-13 | $44.05M 10-Q · filed 2026-08-13 | $65.53M derived: sum of 3 quarters · filed 2026-08-13 | $84.60M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $21.18M 10-Q · filed 2026-05-13 | $42.66M derived: sum of 2 quarters · filed 2026-05-13 | $61.73M derived: sum of 3 quarters · filed 2026-05-13 | $86.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $21.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $40.55M derived: sum of 2 quarters · filed 2026-03-19 | $65.29M derived: sum of 3 quarters · filed 2026-08-13 | $83.25M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $19.07M 10-Q · filed 2025-11-14 | $43.80M derived: sum of 2 quarters · filed 2026-08-13 | $61.77M 10-Q · filed 2025-11-14 | $86.46M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $24.73M 10-Q · filed 2026-08-13 | $42.70M 10-Q · filed 2026-08-13 | $67.39M derived: sum of 3 quarters · filed 2026-08-13 | $87.90M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $17.96M 10-Q · filed 2026-05-13 | $42.66M derived: sum of 2 quarters · filed 2026-05-13 | $63.17M derived: sum of 3 quarters · filed 2026-05-13 | $77.67M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $24.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $45.21M derived: sum of 2 quarters · filed 2026-03-19 | $59.71M derived: sum of 3 quarters · filed 2026-03-19 | $70.58M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $20.51M 10-Q · filed 2025-11-14 | $35.01M derived: sum of 2 quarters · filed 2025-11-14 | $45.88M 10-Q · filed 2025-11-14 | $56.22M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | $14.50M 10-Q · filed 2025-08-14 | $25.37M 10-Q · filed 2025-08-14 | $35.71M derived: sum of 3 quarters · filed 2025-08-14 | $46.91M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $10.87M 10-Q/A · filed 2025-08-14 | $21.21M derived: sum of 2 quarters · filed 2025-08-14 | $32.41M derived: sum of 3 quarters · filed 2025-08-14 | $42.76M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2023-12-31 | $10.34M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-14 | $21.54M derived: sum of 2 quarters · filed 2025-08-14 | $31.89M derived: sum of 3 quarters · filed 2025-08-14 | $43.00M 10-K/A · filed 2025-08-14 | ||||
| 2023-09-30 | $11.20M 10-Q · filed 2024-11-12 | $21.55M derived: sum of 2 quarters · filed 2024-11-12 | $32.66M 10-Q · filed 2024-11-12 | $91.35M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $10.35M 10-Q · filed 2024-08-19 | $21.46M 10-Q · filed 2024-08-19 | $80.15M derived: sum of 3 quarters · filed 2024-08-19 | $90.75M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $11.11M 10-Q/A · filed 2024-08-19 | $69.80M derived: sum of 2 quarters · filed 2024-08-19 | $80.40M derived: sum of 3 quarters · filed 2024-08-19 | $89.68M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2022-12-31 | $58.69M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-19 | $69.29M derived: sum of 2 quarters · filed 2024-08-19 | $78.57M derived: sum of 3 quarters · filed 2024-08-19 | $88.43M 10-K/A · filed 2024-08-19 | ||||
| 2022-09-30 | $10.60M 10-Q · filed 2023-11-09 | $19.88M derived: sum of 2 quarters · filed 2023-11-09 | $29.74M 10-Q · filed 2023-11-09 | $39.13M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $9.28M 10-Q · filed 2023-08-10 | $19.14M 10-Q · filed 2023-08-10 | $28.53M derived: sum of 3 quarters · filed 2023-08-10 | $39.03M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $9.86M 10-Q · filed 2023-05-11 | $19.24M derived: sum of 2 quarters · filed 2023-05-11 | $29.75M derived: sum of 3 quarters · filed 2023-05-11 | $37.72M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $9.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $19.89M derived: sum of 2 quarters · filed 2023-03-30 | $27.86M derived: sum of 3 quarters · filed 2023-03-30 | $36.87M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $10.51M 10-Q · filed 2022-11-14 | $18.48M derived: sum of 2 quarters · filed 2022-11-14 | $27.48M 10-Q · filed 2022-11-14 | $33.83M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $7.97M 10-Q · filed 2022-08-11 | $16.98M 10-Q · filed 2022-08-11 | $23.32M derived: sum of 3 quarters · filed 2022-08-11 | $29.47M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $9.01M 10-Q · filed 2022-05-12 | $15.35M derived: sum of 2 quarters · filed 2022-05-12 | $21.50M derived: sum of 3 quarters · filed 2022-05-12 | $24.09M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $12.50M derived: sum of 2 quarters · filed 2022-03-24 | $15.09M derived: sum of 3 quarters · filed 2022-03-24 | $18.46M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $6.15M 10-Q · filed 2021-11-12 | $8.74M derived: sum of 2 quarters · filed 2021-11-12 | $12.12M 10-Q · filed 2021-11-12 | $16.28M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $2.59M 10-Q · filed 2021-08-12 | $5.97M 10-Q · filed 2021-08-12 | $10.14M derived: sum of 3 quarters · filed 2021-08-12 | $13.06M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $3.38M 10-Q · filed 2021-05-14 | $7.54M derived: sum of 2 quarters · filed 2021-05-14 | $10.46M derived: sum of 3 quarters · filed 2021-05-14 | $14.55M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $7.09M derived: sum of 2 quarters · filed 2021-03-31 | $11.18M derived: sum of 3 quarters · filed 2021-03-31 | $16.05M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $2.92M 10-Q · filed 2020-11-16 | $7.01M derived: sum of 2 quarters · filed 2020-11-16 | $11.88M 10-Q · filed 2020-11-16 | $16.46M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $4.09M 10-Q · filed 2020-08-14 | $8.96M 10-Q · filed 2020-08-14 | $13.54M derived: sum of 3 quarters · filed 2020-08-14 | $17.04M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $4.88M 10-Q · filed 2020-05-15 | $9.45M derived: sum of 2 quarters · filed 2020-05-15 | $12.95M derived: sum of 3 quarters · filed 2020-05-15 | $16.14M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $8.08M derived: sum of 2 quarters · filed 2020-03-17 | $11.27M derived: sum of 3 quarters · filed 2020-03-17 | $14.06M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $3.50M 10-Q · filed 2019-11-13 | $6.69M derived: sum of 2 quarters · filed 2019-11-13 | $9.48M 10-Q · filed 2019-11-13 | $11.59M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $3.19M 10-Q · filed 2019-08-13 | $5.98M 10-Q · filed 2019-08-13 | $8.09M derived: sum of 3 quarters · filed 2019-08-13 | $11.05M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | $2.79M 10-Q · filed 2019-05-14 | $4.90M derived: sum of 2 quarters · filed 2019-05-14 | $7.87M derived: sum of 3 quarters · filed 2019-05-14 | $14.53M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $5.07M derived: sum of 2 quarters · filed 2019-03-28 | $11.74M derived: sum of 3 quarters · filed 2019-03-28 | $13.12M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $2.96M 10-Q · filed 2018-11-13 | $9.63M derived: sum of 2 quarters · filed 2018-11-13 | $11.02M 10-Q · filed 2018-11-13 | $12.48M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $6.67M 10-Q · filed 2018-08-07 | $8.05M 10-Q · filed 2018-08-07 | $9.52M derived: sum of 3 quarters · filed 2018-08-07 | $11.13M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | $1.39M 10-Q · filed 2018-05-11 | $3.89M 10-Q · filed 2017-05-03 | $2.85M derived: sum of 2 quarters · filed 2018-05-11 | $4.47M derived: sum of 3 quarters · filed 2018-05-11 | $5.40M derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $3.08M derived: sum of 2 quarters · filed 2018-04-02 | $4.02M derived: sum of 3 quarters · filed 2018-04-02 | $5.13M 10-K · filed 2018-04-02 | $38.12M 10-K · filed 2017-03-03 | |||
| 2016-09-30 | $1.62M 10-Q · filed 2017-11-08 | $9.31M 10-Q · filed 2016-11-03 | $2.55M derived: sum of 2 quarters · filed 2017-11-08 | $3.66M 10-Q · filed 2017-11-08 | $34.36M 10-Q · filed 2016-11-03 | $25.10M derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | $932.00K 10-Q · filed 2017-08-09 | $13.57M 10-Q · filed 2016-08-04 | $2.04M 10-Q · filed 2017-08-09 | $25.05M 10-Q · filed 2016-08-04 | $23.48M derived: sum of 3 quarters · filed 2017-08-09 | $35.39M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | $11.48M 10-Q · filed 2017-05-03 | $22.55M derived: sum of 2 quarters · filed 2017-05-03 | $34.46M derived: sum of 3 quarters · filed 2017-05-03 | $43.44M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | $11.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $22.98M derived: sum of 2 quarters · filed 2017-03-03 | $31.96M derived: sum of 3 quarters · filed 2017-03-03 | $45.26M 10-K · filed 2017-03-03 | ||||
| 2015-09-30 | $11.91M 10-Q · filed 2016-11-03 | $20.89M derived: sum of 2 quarters · filed 2016-11-03 | $34.19M 10-Q · filed 2016-11-03 | $40.45M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | $8.98M 10-Q · filed 2016-08-04 | $22.28M 10-Q · filed 2016-08-04 | $28.54M derived: sum of 3 quarters · filed 2017-03-03 | $34.97M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-03-31 | $13.30M 10-Q · filed 2016-05-10 | $19.56M derived: sum of 2 quarters · filed 2017-03-03 | $25.98M derived: sum of 3 quarters · filed 2017-03-03 | $31.87M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2014-12-31 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $12.69M derived: sum of 2 quarters · filed 2017-03-03 | $18.57M derived: sum of 3 quarters · filed 2017-03-03 | $23.46M 10-K · filed 2017-03-03 | ||||
| 2014-09-30 | $6.42M 10-Q · filed 2015-11-10 | $12.31M derived: sum of 2 quarters · filed 2015-11-10 | $17.20M 10-Q · filed 2015-11-10 | $22.75M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | $5.88M 10-Q · filed 2015-08-12 | $10.78M 10-Q · filed 2015-08-12 | $16.33M derived: sum of 3 quarters · filed 2016-03-10 | $19.69M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | $4.89M 10-Q · filed 2015-05-12 | $10.44M derived: sum of 2 quarters · filed 2016-03-10 | $13.81M derived: sum of 3 quarters · filed 2016-03-10 | |||||
| 2013-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $8.91M derived: sum of 2 quarters · filed 2016-03-10 | $15.75M 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | $3.37M 10-Q · filed 2014-11-13 | $10.20M 10-Q · filed 2014-11-13 | ||||||
| 2012-12-31 | $9.65M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |